{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:19:23Z","timestamp":1772165963444,"version":"3.50.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:00:00Z","timestamp":1707523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:00:00Z","timestamp":1707523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Palliat Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In March 2020, the outbreak caused by the SARS-CoV-2 virus was declared a pandemic, resulting in numerous fatalities worldwide. To effectively combat the virus, it would be beneficial to involve professionals who specialize in symptom control for advanced illnesses, working closely with other specialties throughout the illness process. This approach can help manage a range of symptoms, from mild to severe and potentially life-threatening. No studies have been conducted in Portugal to analyse the intervention of Palliative Medicine at the end of life of Covid-19 patients and how it differs from other specialties. This knowledge could help determine the importance of including it in the care of people with advanced Covid-19.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The objective of this study is to examine potential differences in the care provided to patients with Covid-19 during their Last Hours and Days of Life (LHDOL) between those who received care from Palliative Medicine doctors and those who did not.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a retrospective cohort study spanning three months (Dec 2020 to Feb 2021), the duration of the Support Unit especially created to deal with Covid-19 patients. The database included clinical files from 181 patients admitted to the Support Unit, 27 of which died from Covid-19.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Statistically significant differences were identified in the care provided. Specifically, fewer drugs were administered at the time of death, including drugs for dyspnoea, pain and agitation, suspension of futile devices and use of palliative sedation to control refractory symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>End-of-life care and symptomatic control differ when there\u2019s regular follow-up by Palliative Medicine, which may translate less symptomatic suffering and promote a dignified and humane end of life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12904-024-01368-9","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T22:02:31Z","timestamp":1707516151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of palliative care at end-of-life Covid-19 patients \u2013 a small-scale pioneering experience"],"prefix":"10.1186","volume":"23","author":[{"given":"Jo\u00e3o Lu\u00eds","family":"Rodrigues-Ribeiro","sequence":"first","affiliation":[]},{"given":"Lu\u00edsa","family":"Castro","sequence":"additional","affiliation":[]},{"given":"Filipa","family":"Pinto-Ribeiro","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Nunes","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,2,10]]},"reference":[{"key":"1368_CR1","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1007\/s12035-020-02249-x","volume":"58","author":"RE Grolli","year":"2021","unstructured":"Grolli RE, Mingoti ME, Bertollo AG, et al. Impact of COVID-19 in the mental health in elderly: psychological and biological updates. Mol Neurobiol. 2021;58:1905\u201316. https:\/\/doi.org\/10.1007\/s12035-020-02249-x.","journal-title":"Mol Neurobiol"},{"issue":"6585","key":"1368_CR2","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1126\/science","volume":"375","author":"M Merad","year":"2022","unstructured":"Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of COVID-19. Science. 2022;375(6585):1122\u20137. https:\/\/doi.org\/10.1126\/science.","journal-title":"Science"},{"issue":"1","key":"1368_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/molecules26010039","volume":"26","author":"M Khan","year":"2020","unstructured":"Khan M, Adil SF, Alkhathlan HZ, et al. COVID-19: A global challenge with Old History, Epidemiology and Progress so far. Molecules. 2020;26(1):39. https:\/\/doi.org\/10.3390\/molecules26010039.","journal-title":"Molecules"},{"key":"1368_CR4","unstructured":"WHO Director-General\u2019s opening remarks at the media briefing on COVID-19, 11. March 2020, available from https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020, accessed on 21 August 2022."},{"key":"1368_CR5","doi-asserted-by":"publisher","first-page":"e817","DOI":"10.3399\/bjgp20X713021","volume":"70","author":"SYS Wong","year":"2020","unstructured":"Wong SYS, Zhang D, Sit RWS, et al. Impact of COVID-19 on loneliness, mental health, and health service utilisation: a prospective cohort study of older adults with multimorbidity in primary care. Br J Gen Pract. 2020;70:e817\u201324. https:\/\/doi.org\/10.3399\/bjgp20X713021.","journal-title":"Br J Gen Pract"},{"key":"1368_CR6","unstructured":"World Health Organization. 2023, WHO Coronavirus (Covid-19) Dashboard, available from https:\/\/covid19.who.intint accessed on 11 May 2023."},{"key":"1368_CR7","volume-title":"Sustainability in Global Health, Rui Nunes","author":"Healthcare as a Universal Human Right","year":"2022","unstructured":"Healthcare as a Universal Human Right. Sustainability in Global Health, Rui Nunes. New York: Routledge; 2022."},{"issue":"4","key":"1368_CR8","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.jpainsymman.2020.04.027","volume":"60","author":"L Radbruch","year":"2020","unstructured":"Radbruch L, Redefining Palliative Care-A New Consensus-Based Definition, et al. J Pain Symptom Manage. 2020;60(4):754\u201364. https:\/\/doi.org\/10.1016\/j.jpainsymman.2020.04.027.","journal-title":"J Pain Symptom Manage"},{"key":"1368_CR9","unstructured":"Ordem dos M\u00e9dicos. 2023, website da Ordem dos M\u00e9dicos, available from https:\/\/ordemdosmedicos.pt\/criterios-de-admissao-na-competencia-em-medicina-paliativa accessed on 23 May 2023."},{"key":"1368_CR10","unstructured":"Clinica Universidad de Navarra 2021, Gu\u00edas r\u00e1pidas de apoyo y control sintom\u00e1tico en pacientes avanzados con COVID-19. Available from https:\/\/cuidadospaliativos.org\/blog\/wp-content\/uploads\/2020\/03\/Guia-COVID-19.V.2.0_22.3.20.pdf, accessed on 23 July, 2022."},{"issue":"9","key":"1368_CR11","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1111\/imj.15300","volume":"51","author":"AK Wong","year":"2021","unstructured":"Wong AK, Demediuk L, Tay JY, et al. COVID-19 end-of-life care: symptoms and supportive therapy use in an Australian hospital. Intern Med J. 2021;51(9):1420\u20135. https:\/\/doi.org\/10.1111\/imj.15300.","journal-title":"Intern Med J"},{"key":"1368_CR12","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of Coronavirus Disease 2019 (COVID-19): a review. JAMA. 2020;324:782\u201393.","journal-title":"JAMA"},{"key":"1368_CR13","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","volume":"77","author":"L Mao","year":"2020","unstructured":"Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with Coronavirus Disease, 2019 in Wuhan, China. JAMA Neurol. 2020;77:683\u201390.","journal-title":"JAMA Neurol"},{"key":"1368_CR14","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s13054-020-03009-y","volume":"24","author":"YT Chen","year":"2020","unstructured":"Chen YT, Shao SC, Hsu CK, Wu IW, Hung MJ, Chen YC. Incidence of acute kidney injury in COVID-19 infection: a systematic review and meta-analysis. Crit Care. 2020;24:346.","journal-title":"Crit Care"},{"key":"1368_CR15","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S2468-1253(20)30126-6","volume":"5","author":"R Mao","year":"2020","unstructured":"Mao R, Qiu Y, He J-S, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5:667\u201378.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1368_CR16","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.ajem.2020.04.048","volume":"38","author":"B Long","year":"2020","unstructured":"Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med. 2020;38:1504\u20137.","journal-title":"Am J Emerg Med"},{"key":"1368_CR17","doi-asserted-by":"publisher","unstructured":"Juth N, Lindblad A, Lyn\u00f6e N, et al. European Association for Palliative Care (EAPC) framework for palliative sedation: an ethical discussion. BMC Palliat Care. 2010;20. https:\/\/doi.org\/10.1186\/1472-684X-9-20. 9,:.","DOI":"10.1186\/1472-684X-9-20"},{"key":"1368_CR18","first-page":"101","volume":"5","author":"MD Katherine Morrison","year":"2016","unstructured":"Katherine Morrison MD, Jeanie Youngwerth MD. - Palliat Sedation Therapy Hosp Med Clin. 2016;5:101\u201313.","journal-title":"- Palliat Sedation Therapy Hosp Med Clin"},{"key":"1368_CR19","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/S0034-7094(12)70157-5","volume":"62","author":"Fabiola Leite","year":"2012","unstructured":"Fabiola Leite. Nogueira et al- palliative sedation of terminally ill patients. Rev Bras Anestesiol. 2012;62:580\u201359.","journal-title":"Rev Bras Anestesiol"},{"key":"1368_CR20","unstructured":"Davies E, Higginson IJ, editors. Palliative care. The solid facts. Geneva: World Health Organization; 2004. 32 p. available at http:\/\/www.euro.who.int\/document\/E82931.pdf accessed on 12 January 2023."},{"key":"1368_CR21","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1001\/jamainternmed.2015.0289","volume":"175","author":"JS Kutner","year":"2015","unstructured":"Kutner JS, Blatchford PJ, Taylor DH, Christine S, Bull JH, et al. Safety and Benefit of discontinuing statin therapy in the setting of Advanced, Life-limiting illness: a Randomized Clinicaln Trial. JAMA Intern Med. 2015;175:691\u2013700. https:\/\/doi.org\/10.1001\/jamainternmed.2015.0289.","journal-title":"JAMA Intern Med"},{"key":"1368_CR22","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1080\/09699260.2016.11922.2321","volume":"24","author":"O Akinbolade","year":"2016","unstructured":"Akinbolade O, Husband A, Forrest STA. Deprescribing in advanced illness. Prog Palliat Care. 2016;24:268\u201371. https:\/\/doi.org\/10.1080\/09699260.2016.11922.2321.","journal-title":"Prog Palliat Care"},{"key":"1368_CR23","doi-asserted-by":"crossref","unstructured":"Thompson W, Farrell B, Deprescribing. What is it and what does the evidence tell us? Can J Hosp Pharm. 2013;201\u20132.","DOI":"10.4212\/cjhp.v66i3.1261"},{"key":"1368_CR24","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00520-008-0541-y","volume":"17","author":"RP Riechelmann","year":"2009","unstructured":"Riechelmann RP, Krzyzanowska MK. Futile medication use in terminally ill cancer patients. Support Care Cancer. 2009;17:745\u20138. https:\/\/doi.org\/10.1007\/s00520-008-0541-y.","journal-title":"Support Care Cancer"},{"key":"1368_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.24950\/rspmi\/Revis\u00e3o\/139\/1\/2018","volume":"25","author":"I Romero","year":"2018","unstructured":"Romero I. Desprescrever nos doentes em Fim De Vida: um guia para melhorar a Pr\u00e1tica Cl\u00ednica. Rev Port Soc Med Interna. 2018;25:48\u201357. https:\/\/doi.org\/10.24950\/rspmi\/Revisao\/139\/1\/2018.","journal-title":"Rev Port Soc Med Interna"},{"key":"1368_CR26","unstructured":"Di\u00e1rio da Rep\u00fablica Eletr\u00f3nico. 2022, website do Di\u00e1rio da Rep\u00fablica, Despacho n.\u00ba 10942-A\/2020, de 6 de novembro, available at https:\/\/dre.pt\/dre\/detalhe\/despacho\/10942-a-2020-147814594, accessed on 24 March 2023."},{"key":"1368_CR27","unstructured":"de Servi\u00e7o Nacional. Sa\u00fade 2023, website do Servi\u00e7o Nacional De Sa\u00fade, Plano-da-sa\u00fade-para-o-outono-inverno-2020-21, available at www.sns.gov.pt, accessed on 24 February 2023."},{"key":"1368_CR28","unstructured":"Junta de Freguesia de Riba D\u2019Ave. 2022, website da Junta de Freguesia de Riba D\u2019Ave, available from https:\/\/www.jf-ribadeave.pt\/riba-de-ave\/, accessed on 22 October 2022."},{"issue":"1","key":"1368_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jpainsymman.2013.02.021","volume":"47","author":"D Hui","year":"2014","unstructured":"Hui D, Nooruddin Z, Didwaniya N, et al. Concepts and definitions for actively dying, end of life, terminally ill, terminal care, and transition of care: a systematic review. J Pain Symptom Manage. 2014;47(1):77\u201389. https:\/\/doi.org\/10.1016\/j.jpainsymman.2013.02.021.","journal-title":"J Pain Symptom Manage"},{"issue":"8","key":"1368_CR30","doi-asserted-by":"publisher","first-page":"e9503","DOI":"10.7759\/cureus.9503","volume":"12","author":"AI Alsuhail","year":"2020","unstructured":"Alsuhail AI, Punalvasal Duraisamy B, Alkhudhair A, Alshammary SA, AlRehaili A. The Accuracy of Imminent Death diagnosis in a Palliative Care setting. Cureus. 2020;12(8):e9503. https:\/\/doi.org\/10.7759\/cureus.9503.","journal-title":"Cureus"},{"issue":"2","key":"1368_CR31","first-page":"143","volume":"86","author":"J Hackett","year":"2017","unstructured":"Hackett J. The Importance of Holistic Care at the end of life. Ulster Med J. 2017;86(2):143\u20134.","journal-title":"Ulster Med J"},{"issue":"1","key":"1368_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/1534735415617015","volume":"15","author":"S Greer","year":"2016","unstructured":"Greer S, Joseph M, Palliative Care. A holistic Discipline. Integr Cancer Ther. 2016;15(1):5\u20139. https:\/\/doi.org\/10.1177\/1534735415617015.","journal-title":"Integr Cancer Ther"},{"issue":"3","key":"1368_CR33","doi-asserted-by":"publisher","first-page":"e234723","DOI":"10.1001\/jamanetworkopen.2023.4723","volume":"6","author":"A Mortsiefer","year":"2023","unstructured":"Mortsiefer A, L\u00f6scher S, Pashutina Y, et al. Family conferences to facilitate deprescribing in older outpatients with Frailty and with polypharmacy: the COFRAIL Cluster Randomized Trial. JAMA Netw Open. 2023;6(3):e234723. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.4723.","journal-title":"JAMA Netw Open"},{"issue":"10","key":"1368_CR34","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1089\/jpm.2013.0538","volume":"17","author":"R Powazki","year":"2014","unstructured":"Powazki R, Walsh D, Hauser K, Davis MP. Communication in palliative medicine: a clinical review of family conferences. J Palliat Med. 2014;17(10):1167\u201377. https:\/\/doi.org\/10.1089\/jpm.2013.0538.","journal-title":"J Palliat Med"},{"key":"1368_CR35","doi-asserted-by":"publisher","unstructured":"B\u00e5ngsbo A, Dun\u00e9r A, Lid\u00e9n E. Patient participation in discharge planning conference. Int J Integr Care. 2014;14(e030). https:\/\/doi.org\/10.5334\/ijic.1543.","DOI":"10.5334\/ijic.1543"},{"key":"1368_CR36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/clpt.2008.211","volume":"85","author":"H Holmes","year":"2009","unstructured":"Holmes H. Rational prescribing for patients with a reduced life expectancy. Clin Pharmacol Ther. 2009;85:103\u20137.","journal-title":"Clin Pharmacol Ther"},{"key":"1368_CR37","doi-asserted-by":"publisher","first-page":"511","DOI":"10.2165\/11631740-000000000-00000","volume":"29","author":"AJ Cruz-Jentoft","year":"2012","unstructured":"Cruz-Jentoft AJ, Boland B, Rexach L. Drug therapy optimization at the end of life. Drugs Aging. 2012;29:511\u201321.","journal-title":"Drugs Aging"},{"key":"1368_CR38","doi-asserted-by":"publisher","first-page":"220","DOI":"10.4143\/crt.2013.45.3.220","volume":"45","author":"HR Lee","year":"2013","unstructured":"Lee HR, Yi SY, Kim DY. Evaluation of prescribing medications for terminal Cancer patients near death: essential or futile. Cancer Res Treat. 2013;45:220\u20135.","journal-title":"Cancer Res Treat"},{"key":"1368_CR39","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1007\/s00520-015-3007-z","volume":"24","author":"KA Kierner","year":"2016","unstructured":"Kierner KA, Weixler D, Masel EK, Gartner V, Watzke HH. Polypharmacy in the terminal stage of cancer. Support Care Cancer. 2016;24:2067\u201374.","journal-title":"Support Care Cancer"},{"key":"1368_CR40","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/j.1532-5415.2007.01124.x","volume":"55","author":"DC Currow","year":"2007","unstructured":"Currow DC, Stevenson JP, Abernethy AP, Plummer J, Shelby-James TM. Prescribing in palliative care as death approaches: polypharmacy in palliative care. J Am Geriatr Soc. 2007;55:590\u20135.","journal-title":"J Am Geriatr Soc"},{"key":"1368_CR41","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12904-021-00875-3","volume":"20","author":"MS Boddaert","year":"2021","unstructured":"Boddaert MS, Stoppelenburg A, Hasselaar J, van der Linden YM, Vissers KCP, Raijmakers NJH, et al. Specialist palliative care teams and characteristics related to referral rate: a national cross-sectional survey among hospitals in the Netherlands. BMC Palliat Care. 2021;20:175.","journal-title":"BMC Palliat Care"},{"key":"1368_CR42","first-page":"15","volume":"47","author":"RH Howland","year":"2009","unstructured":"Howland RH. Effects of aging on pharmacokinetic and pharmacodynamic drug processes. J Psychosoc Nurs Ment Health Serv. 2009;47:15\u20138.","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"key":"1368_CR43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/0269216318801124","volume":"33","author":"K Paque","year":"2019","unstructured":"Paque K, Vander Stichele R, Elseviers M, Pardon K, Dilles T, Deliens L, et al. Barriers and enablers to deprescribing in people with a life-limiting disease: a systematic review. Palliat Med. 2019;33:37\u201348.","journal-title":"Palliat Med"},{"key":"1368_CR44","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.jamda.2016.01.015","volume":"17","author":"RTCM van Nordennen","year":"2016","unstructured":"van Nordennen RTCM, Lavrijsen JCM, Heesterbeek MJAB, Bor H, Vissers KCP, Koopmans RTCM. Changes in prescribed drugs between admission and the end of life in patients admitted to palliative care facilities. J Am Med Dir Assoc. 2016;17:514\u20138.","journal-title":"J Am Med Dir Assoc"},{"key":"1368_CR45","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1089\/jpm.2018.0559","volume":"22","author":"A Wenedy","year":"2019","unstructured":"Wenedy A, Lim YQ, Lin Ronggui CK, Koh GCH, Chong PH, Chew LST. A study of medication use of Cancer and non-cancer patients in home hospice care in Singapore: a retrospective study from 2011 to 2015. J Palliat Med. 2019;22:1243\u201351.","journal-title":"J Palliat Med"},{"key":"1368_CR46","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11845-012-0841-6","volume":"182","author":"S McLean","year":"2013","unstructured":"McLean S, Sheehy-Skeffington B, O\u2019Leary N, O\u2019Gorman A. Pharmacological management of co-morbid conditions at the end of life: is less more? Ir J Med Sci. 2013;182:107\u201312.","journal-title":"Ir J Med Sci"},{"key":"1368_CR47","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12875-023-02084-8","volume":"24","author":"SSL Goh","year":"2023","unstructured":"Goh SSL, Lai PSM, Ramdzan SN, et al. Weighing the necessities and concerns of deprescribing among older ambulatory patients and primary care trainees: a qualitative study. BMC Prim Care. 2023;24:136. https:\/\/doi.org\/10.1186\/s12875-023-02084-8.","journal-title":"BMC Prim Care"},{"key":"1368_CR48","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12904-023-01156-x","volume":"22","author":"M Rijpstra","year":"2023","unstructured":"Rijpstra M, Kuip E, Hasselaar J, et al. The clinical practice of palliative sedation in patients dying from COVID-19: a retrospective chart review. BMC Palliat Care. 2023;22:34. https:\/\/doi.org\/10.1186\/s12904-023-01156-x.","journal-title":"BMC Palliat Care"},{"issue":"8","key":"1368_CR49","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1177\/10499091211046233","volume":"39","author":"TS Beng","year":"2022","unstructured":"Beng TS, Kim CLC, Shee CC, et al. COVID-19, suffering and Palliative Care: a review. Am J Hosp Palliat Care. 2022;39(8):986\u201395. https:\/\/doi.org\/10.1177\/10499091211046233.","journal-title":"Am J Hosp Palliat Care"},{"issue":"1","key":"1368_CR50","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1016\/j.jpainsymman.2020.04.015","volume":"60","author":"N Lovell","year":"2020","unstructured":"Lovell N, Maddocks M, Etkind SN, et al. Characteristics, Symptom Management, and outcomes of 101 patients with COVID-19 referred for Hospital Palliative Care. J Pain Symptom Manage. 2020;60(1):e77\u2013e81.","journal-title":"J Pain Symptom Manage"},{"issue":"9","key":"1368_CR51","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3390\/medicina57090873","volume":"57","author":"JM Ramos-Rincon","year":"2021","unstructured":"Ramos-Rincon JM, Moreno-Perez O, Gomez-Martinez N, et al. Palliative Sedation in COVID-19 end-of-Life Care. Retrospective Cohort Study Medicina (Kaunas). 2021;57(9):873. https:\/\/doi.org\/10.3390\/medicina57090873. Published 2021 Aug 26.","journal-title":"Retrospective Cohort Study Medicina (Kaunas)"},{"issue":"6","key":"1368_CR52","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00482-008-0705-1","volume":"22","author":"S Stiel","year":"2008","unstructured":"Stiel S, Krumm N, Schroers O, Radbruch L, Elsner F. Indikationen Und Gebrauch Von Benzodiazepinen auf einer palliativstation [Indications and use of benzodiazepines in a palliative care unit]. Schmerz. 2008;22(6):665\u201371. https:\/\/doi.org\/10.1007\/s00482-008-0705-1.","journal-title":"Schmerz"},{"issue":"6","key":"1368_CR53","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1159\/000520975","volume":"50","author":"H Senderovich","year":"2022","unstructured":"Senderovich H, Gardner S, Berall A, Ganion M, Zhang D, Vinoraj D, Waicus S. Benzodiazepine Use and Morbidity-Mortality outcomes in a geriatric Palliative Care Unit: a retrospective review. Dement Geriatr Cogn Disord 3 March. 2022;50(6):559\u201367. https:\/\/doi.org\/10.1159\/000520975.","journal-title":"Dement Geriatr Cogn Disord 3 March"},{"key":"1368_CR54","doi-asserted-by":"publisher","first-page":"e612","DOI":"10.1136\/spcare-2022-004080","volume":"13","author":"B Bowers","year":"2023","unstructured":"Bowers B, et al. BMJ Supportive & Palliative Care. 2023;13:e612\u201323. https:\/\/doi.org\/10.1136\/spcare-2022-004080.","journal-title":"BMJ Supportive & Palliative Care"},{"key":"1368_CR55","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ijid.2021.02.053","volume":"105","author":"N Mumoli","year":"2021","unstructured":"Mumoli N, Florian C, Cei M, Evangelista I, Colombo A, Razionale G, Moroni L, Mazzone A. Palliative care in a COVID-19 Internal Medicine ward: a preliminary report. Int J Infect Dis. 2021;105:141\u20133. https:\/\/doi.org\/10.1016\/j.ijid.2021.02.053.","journal-title":"Int J Infect Dis"},{"key":"1368_CR56","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/jgs.16507","volume":"68","author":"H Sun","year":"2020","unstructured":"Sun H, Lee J, Meyer BJ, Myers EL, Nishikawa MS, Tischler JL, Blinderman CD. Characteristics and Palliative Care needs of COVID-19 patients receiving Comfort-Directed Care. J Am Geriatr Soc. 2020;68:1162\u20134. https:\/\/doi.org\/10.1111\/jgs.16507.","journal-title":"J Am Geriatr Soc"},{"key":"1368_CR57","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1016\/j.jpainsymman.2020.04.015","volume":"60","author":"N Lovell","year":"2020","unstructured":"Lovell N, Maddocks M, Etkind SN, Taylor K, Carey I, Vora V, Marsh L, Higginson IJ, Prentice W, Edmonds P, et al. Characteristics, Symptom Management, and outcomes of 101 patients with COVID-19 referred for Hospital Palliative Care. J Pain Symptom Manag. 2020;60:e77\u2013e81. https:\/\/doi.org\/10.1016\/j.jpainsymman.2020.04.015.","journal-title":"J Pain Symptom Manag"},{"key":"1368_CR58","doi-asserted-by":"publisher","DOI":"10.1111\/imj.15300","author":"AK Wong","year":"2021","unstructured":"Wong AK, Demediuk L, Tay JY, Wawryk O, Collins A, Everitt R, Philip J, Buising K. Le B. COVID-19 end-of-life care: symptoms and supportive therapy use in an Australian hospital. Intern Med J. 2021. https:\/\/doi.org\/10.1111\/imj.15300.","journal-title":"Intern Med J"},{"key":"1368_CR59","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1177\/0269216320947312","volume":"34","author":"B Alderman","year":"2020","unstructured":"Alderman B, Webber K, Davies A. An audit of end-of-life symptom control in patients with corona virus disease 2019 (COVID-19) dying in a hospital in the United Kingdom. Palliat Med. 2020;34:1249\u201355. https:\/\/doi.org\/10.1177\/0269216320947312.","journal-title":"Palliat Med"},{"key":"1368_CR60","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1177\/0269216320935361","volume":"34","author":"T Jackson","year":"2020","unstructured":"Jackson T, Hobson K, Clare H, Weegmann D, Moloughney C, McManus S. End-of-life care in COVID-19: an audit of pharmacological management in hospital inpatients. Palliat Med SAGE. 2020;34:1235\u201340. https:\/\/doi.org\/10.1177\/0269216320935361.","journal-title":"Palliat Med SAGE"},{"issue":"19","key":"1368_CR61","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.3390\/jcm11195925","volume":"11","author":"T Tenge","year":"2022","unstructured":"Tenge T, et al. Specialist Palliative Care consultations in COVID-19 patients in the ICU-A retrospective analysis of patient characteristics and symptoms at a German University Hospital. J Clin Med. 2022;11(19):5925. https:\/\/doi.org\/10.3390\/jcm11195925. PMID: 36233792; PMCID: PMC9571329).","journal-title":"J Clin Med"},{"key":"1368_CR62","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00520-008-0479-0","volume":"17","author":"KE Clemens","year":"2009","unstructured":"Clemens KE, Quednau I, Klaschik E. Use of oxygen and opioids in the palliation of dyspnoea in hypoxic and non-hypoxic palliative care patients: a prospective study. Support Care Cancer. 2009;17:367\u201377.","journal-title":"Support Care Cancer"},{"key":"1368_CR63","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/S0140-6736(10)61115-4","volume":"376","author":"AP Abernethy","year":"2010","unstructured":"Abernethy AP, McDonald CF, Frith PA, et al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet. 2010;376:784\u201393.","journal-title":"Lancet"},{"issue":"1","key":"1368_CR64","first-page":"7","volume":"117","author":"L Quinn-Lee","year":"2018","unstructured":"Quinn-Lee L, Weggel J, Moch SD. Use of Oxygen at the end of life: attitudes, beliefs, and practices in Wisconsin. WMJ. 2018;117(1):7\u201312.","journal-title":"WMJ"},{"issue":"5","key":"1368_CR65","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.3390\/nu13051562","volume":"13","author":"E S\u00e1nchez-S\u00e1nchez","year":"2021","unstructured":"S\u00e1nchez-S\u00e1nchez E, Ruano-\u00c1lvarez MA, D\u00edaz-Jim\u00e9nez J, D\u00edaz AJ, Ordonez FJ. Enteral Nutrition by Nasogastric Tube in Adult patients under Palliative Care: a systematic review. Nutrients. 2021;13(5):1562. https:\/\/doi.org\/10.3390\/nu13051562. Published 2021 May 6.","journal-title":"Nutrients"},{"key":"1368_CR66","doi-asserted-by":"crossref","unstructured":"Good P, Cavenagh J, Mather M, Ravenscroft P. Medically assisted nutrition for palliative care in adult patients. Cochrane Database Syst Rev. 2008, CD006274.","DOI":"10.1002\/14651858.CD006274.pub2"},{"key":"1368_CR67","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1111\/jgs.12924","volume":"62","author":"American Geriatrics Society Ethics Committee and Clinical Practice and Models of Care Committee","year":"2014","unstructured":"American Geriatrics Society Ethics Committee and Clinical Practice and Models of Care Committee. American Geriatrics Society Feeding Tubes in Advanced Dementia position Statement. J Am Geriatr Soc. 2014;62:1590\u20133.","journal-title":"J Am Geriatr Soc"},{"key":"1368_CR68","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1186\/s12877-020-01931-y","volume":"20","author":"K Anantapong","year":"2020","unstructured":"Anantapong K, Davies N, Chan J, McInnerney D, Sampson EL. Mapping and understanding the decision-making process for providing nutrition and hydration to people living with dementia: a systematic review. BMC Geriatr. 2020;20:520.","journal-title":"BMC Geriatr"},{"key":"1368_CR69","first-page":"245","volume":"61","author":"I Ying","year":"2015","unstructured":"Ying I. Artificial nutrition and hydration in advanced dementia. Can Fam Physician. 2015;61:245\u20138.","journal-title":"Can Fam Physician"},{"key":"1368_CR70","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1001\/jama.2010.79","volume":"303","author":"JM Teno","year":"2010","unstructured":"Teno JM. Hospital Characteristics Associated with Feeding Tube Placement in nursing home residents with Advanced Cognitive Impairment. JAMA. 2010;303:544\u201350.","journal-title":"JAMA"},{"issue":"5","key":"1368_CR71","doi-asserted-by":"publisher","first-page":"e250","DOI":"10.1016\/j.jpainsymman.2022.07.006","volume":"64","author":"U Wernli","year":"2022","unstructured":"Wernli U, D\u00fcrr F, Jean-Petit-Matile S, Kobleder A, Meyer-Massetti C. Subcutaneous drugs and off-label use in Hospice and Palliative Care: a scoping review. J Pain Symptom Manage. 2022;64(5):e250\u20139. https:\/\/doi.org\/10.1016\/j.jpainsymman.2022.07.006.","journal-title":"J Pain Symptom Manage"},{"issue":"6","key":"1368_CR72","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0885-3924(92)90085-v","volume":"7","author":"RL Fainsinger","year":"1992","unstructured":"Fainsinger RL, MacEachern T, Hanson J, Bruera E. The use of urinary catheters in terminally ill cancer patients. J Pain Symptom Manage. 1992;7(6):333\u20138. https:\/\/doi.org\/10.1016\/0885-3924(92)90085-v.","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"1368_CR73","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1089\/pmr.2020.0060","volume":"1","author":"R Pais","year":"2020","unstructured":"Pais R, Lee P, Cross S, Gebski V, Aggarwal R. Bladder care in Palliative Care inpatients: a prospective dual site Cohort Study. Palliat Med Rep. 2020;1(1):251\u20138. https:\/\/doi.org\/10.1089\/pmr.2020.0060. Published 2020 Oct 30.","journal-title":"Palliat Med Rep"},{"issue":"1","key":"1368_CR74","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1001\/jamainternmed.2015.6443","volume":"176","author":"KE Covinsky","year":"2016","unstructured":"Covinsky KE. Risks Associated with catheters. JAMA Intern Med. 2016;176(1):115. https:\/\/doi.org\/10.1001\/jamainternmed.2015.6443.","journal-title":"JAMA Intern Med"},{"key":"1368_CR75","doi-asserted-by":"publisher","unstructured":"Alsuhail AI, Punalvasal Duraisamy B, Alkhudhair A, Alshammary SA, AlRehaili A. The Accuracy of Imminent Death Diagnosis in a Palliative Care Setting. Cureus. 2020;12(8):e9503. Published 2020 Aug 1. https:\/\/doi.org\/10.7759\/cureus.9503.","DOI":"10.7759\/cureus.9503"}],"container-title":["BMC Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-024-01368-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12904-024-01368-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-024-01368-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T22:03:17Z","timestamp":1707516197000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpalliatcare.biomedcentral.com\/articles\/10.1186\/s12904-024-01368-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,10]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1368"],"URL":"https:\/\/doi.org\/10.1186\/s12904-024-01368-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3302996\/v1","asserted-by":"object"}]},"ISSN":["1472-684X"],"issn-type":[{"value":"1472-684X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,10]]},"assertion":[{"value":"28 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in compliance with the Declaration of Helsinki. The Ethics Committee of Hospital Narciso Ferreira approved this trial (CES-SCMRA 007\/2021). All methods were performed following relevant guidelines and regulations. Informed consent was obtained from all subjects and\/or their legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}